19
Publications
2K
Citations
17
H-Index
1997
Active since
Xingrong Liu is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryDrug DevelopmentAsthmaPharmacotherapySmall Molecules
Publications per year
1997–2023
19
19
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Reina N. Fuji, Michael Flagella, Miriam Baca et al. · Science Translational Medicine · 2015 · 363 citations
Xingrong Liu, Bill J. Smith, Cuiping Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 182 citations
Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 160 citations · Full text
Small Molecule Inhibitors, Broad Kinase Selectivity, Drug Target +19
Rows per page
1–5 of 19